Clinical Spectrum of Ischaemic Arterial Diseases Associated with COVID-19: a Series of Four Illustrative Cases
Overview
Authors
Affiliations
Background: Severe coronavirus-induced disease 2019 (COVID-19) leads to acute respiratory distress syndrome with an increased risk of venous thrombo-embolic events. To a much lesser extent, arterial thrombo-embolic events have also been reported in this setting.
Case Summary: Here, we describe four different cases of COVID-19 infection with ischaemic arterial events, such as a myocardial infarction with high thrombus load, ischaemic stroke on spontaneous thrombosis of the aortic valve, floating thrombus with mesenteric, splenic and renal infarction, and acute limb ischaemia.
Discussion: Cardiovascular risk factors such as hypertension, obesity, and diabetes are comorbidities most frequently found in patients with a severe COVID-19 infection and are associated with a higher death rate. Our goal is to provide an overview of the clinical spectrum of ischaemic arterial events that may either reveal or complicate COVID-19. Several suspected pathophysiological mechanisms could explain the association between cardiovascular events and COVID-19 (role of systemic inflammatory response syndrome, endothelial dysfunction, activation of coagulation cascade leading to a hypercoagulability state, virus-induced secondary antiphospholipid syndrome). We need additional studies of larger size, to estimate the incidence of these arterial events and to assess the efficacy of anticoagulation therapy.
Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review.
Gomes R, Salina M, Pironatto V, Lepinski J, Gueiber T, Juliatto B J Vasc Bras. 2025; 24:e20230128.
PMID: 39949953 PMC: 11815833. DOI: 10.1590/1677-5449.202301282.
Acute Limb Ischemia in COVID-19: A Systematic Review.
Indriani S, Amshar M, Nugraha R, Siddiq T, Adiarto S Int J Angiol. 2023; 32(4):215-226.
PMID: 37927841 PMC: 10624540. DOI: 10.1055/s-0043-1771250.
Venous thromboembolism with renal infarct due to paradoxical embolism.
Aggarwal N, Rector D, Lazar N, Bukovec F BMJ Case Rep. 2023; 16(3).
PMID: 36977511 PMC: 10069490. DOI: 10.1136/bcr-2022-252322.
Vitronectin promotes immunothrombotic dysregulation in the venular microvasculature.
Uhl B, Haring F, Slotta-Huspenina J, Luft J, Schneewind V, Hildinger J Front Immunol. 2023; 14:1078005.
PMID: 36845099 PMC: 9945350. DOI: 10.3389/fimmu.2023.1078005.
COVID-19 and antiphospholipid antibodies.
Butt A, Erkan D, Lee A Best Pract Res Clin Haematol. 2022; 35(3):101402.
PMID: 36494152 PMC: 9568270. DOI: 10.1016/j.beha.2022.101402.